Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ginard

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
United European Gastroenterology Journal|January 8, 2025
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCUL Madero-Velázquez, A Mínguez, L Mayorga, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
United European Gastroenterology Journal|January 8, 2025
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCUL Madero-Velázquez, A Mínguez, L Mayorga, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Pageof 3